TFRC and breast cancer: Keeping in mind that TfR expression is up to five times higher in malignant compared to normal tissue10, DOX–Tf conjugate should allow us to increase the intracellular concentration of drugs in breast cancer cells and thus help to overcome their chemoresistance15.